Patents by Inventor Mary Ellen Davies

Mary Ellen Davies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040180329
    Abstract: Synthetic DNA molecules encoding HIV gag and modifications of HIV gag are provided. The codons of the synthetic molecules are codons preferred by the projected host cell. The synthetic molecules may be used as a polynucleotide vaccine which provides effective immunoprophylaxis against HIV infection through stimulation of neutralizing antibody and cell-mediated immunity.
    Type: Application
    Filed: October 5, 2003
    Publication date: September 16, 2004
    Inventors: John W. Shiver, Mary Ellen Davies, Daniel C. Freed, Margaret A. Liu, Helen C. Perry
  • Patent number: 6696291
    Abstract: Synthetic DNA molecules encoding HIV gag and modifications of HIV gag are provided. The codons of the synthetic molecules are codons preferred by the projected host cell. The synthetic molecules may be used as a polynucleotide vaccine which provides effective immunoprophylaxis against HIV infection through stimulation of neutralizing antibody and cell-mediated immunity.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: February 24, 2004
    Assignee: Merck & Co., Inc.
    Inventors: John W. Shiver, Daniel C. Freed, Mary Ellen Davies, Margaret A. Liu, Helen C. Perry
  • Publication number: 20030229214
    Abstract: Synthetic polynucleotides comprising a DNA sequence encoding a peptide or protein are provided. The DNA sequence of the synthetic polynucleotides comprise codons optimized for expression in a nonhomologous host. The invention is exemplified by synthetic DNA molecules encoding HIV env as well as modifications of HIV env. The codons of the synthetic molecules include the projected host cell's preferred codons. The synthetic molecules provide preferred forms of foreign genetic material. The synthetic molecules may be used as a polynucleotide vaccine which provides immunoprophylaxis against HIV infection through neutralizing antibody and cell-mediated immunity. This invention provides polynucleotides which, when directly introduced into a vertebrate in vivo, including mammals such as primates and humans, induces the expression of encoded proteins within the animal.
    Type: Application
    Filed: February 17, 2003
    Publication date: December 11, 2003
    Inventors: John W. Shiver, Mary Ellen Davies, Daniel C. Freed, Margaret A. Liu, Helen C. Perry
  • Publication number: 20030087225
    Abstract: Synthetic DNA molecules encoding HIV genes and modifications of HIV genes are provided. The codons of the synthetic molecules use codons preferred by the projected host cell. The synthetic molecules may be used as a polynucleotide vaccine which provides effective immunoprophylaxis against HIV infection through neutralizing antibody and cell-mediated immunity.
    Type: Application
    Filed: May 20, 2002
    Publication date: May 8, 2003
    Inventors: John W. Shiver, Mary Ellen Davies, Daniel C. Freed, Margaret A. Liu, Helen C. Perry
  • Patent number: 6534312
    Abstract: Synthetic polynucleotides comprising a DNA sequence encoding a peptide or protein are provided. The DNA sequence of the synthetic polynucleotides comprise codons optimized for expression in a nonhomologous host. The invention is exemplified by synthetic DNA molecules encoding HIV env as well as modifications of HIV env. The codons of the synthetic molecules include the projected host cell's preferred codons. The synthetic molecules provide preferred forms of foreign genetic material. The synthetic molecules may be used as a polynucleotide vaccine which provides immunoprophylaxis against HIV infection through neutralizing antibody and cell-mediated immunity. This invention provides polynucleotides which, when directly introduced into a vertebrate in vivo, including mammals such as primates and humans, induces the expression of encoded proteins within the animal.
    Type: Grant
    Filed: June 28, 1999
    Date of Patent: March 18, 2003
    Assignee: Merck & Co., Inc.
    Inventors: John W. Shiver, Mary Ellen Davies, Daniel C. Freed, Margaret A. Liu, Helen C. Perry
  • Publication number: 20030050468
    Abstract: Synthetic DNA molecules encoding HIV gag and modifications of HIV gag are provided. The codons of the synthetic molecules are codons preferred by the projected host cell. The synthetic molecules may be used as a polynucleotide vaccine which provides effective immunoprophylaxis against HIV infection through stimulation of neutralizing antibody and cell-mediated immunity.
    Type: Application
    Filed: October 9, 2001
    Publication date: March 13, 2003
    Inventors: John W. Shiver, Daniel C. Freed, Mary Ellen Davies, Margaret A. Liu, Helen C. Perry